2,5-dimethoxy-4-bromoamphetamine and Glaucoma, Suspect

2,5-dimethoxy-4-bromoamphetamine has been researched along with Glaucoma, Suspect in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bondarev, ML; Glennon, RA; Hellberg, MR; Khorana, N; May, JA; McLaughlin, MA; Sharif, NA; Young, R	1

Other Studies

1 other study(ies) available for 2,5-dimethoxy-4-bromoamphetamine and Glaucoma, Suspect

Article	Year
Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24 Topics: Animals; Antihypertensive Agents; Binding, Competitive; Blood-Brain Barrier; Cerebral Cortex; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Intraocular Pressure; Macaca fascicularis; Male; Ocular Hypertension; Oxygen; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship	2004

Article

Year

Beta-oxygenated analogues of the 5-HT2A serotonin receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane.

Journal of medicinal chemistry, 2004, Nov-18, Volume: 47, Issue:24

Topics: Animals; Antihypertensive Agents; Binding, Competitive; Blood-Brain Barrier; Cerebral Cortex; Discrimination Learning; DOM 2,5-Dimethoxy-4-Methylamphetamine; Intraocular Pressure; Macaca fascicularis; Male; Ocular Hypertension; Oxygen; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin 5-HT2 Receptor Agonists; Stereoisomerism; Structure-Activity Relationship

2004